Altered circadian clock as a novel therapeutic target for constant darkness-induced insulin resistance and hyperandrogenism of polycystic ovary syndrome
- Resource Type
- Article
- Source
- In
Translational Research May 2020 219:13-29 - Subject
- Language
- ISSN
- 1931-5244